Matthew J. Bernett

Person

Monrovia, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Engineered IL-2 Fc fusion proteins
- Patent number 11,981,717
- Issue date May 14, 2024
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,945,880
- Issue date Apr 2, 2024
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved proper...
- Patent number 11,932,675
- Issue date Mar 19, 2024
- Genentech, Inc.
- John Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and GPC3
- Patent number 11,859,012
- Issue date Jan 2, 2024
- Xencor, Inc.
- Alex Nisthal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,859,011
- Issue date Jan 2, 2024
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted IL-12 heterodimeric Fc-fusion proteins
- Patent number 11,851,466
- Issue date Dec 26, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies that bind to CD38 and CD3
- Patent number 11,840,579
- Issue date Dec 12, 2023
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric proteins
- Patent number 11,814,423
- Issue date Nov 14, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CLDN6
- Patent number 11,739,144
- Issue date Aug 29, 2023
- Xencor, Inc.
- Matthew S. Faber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific binding agents binding to CLDN18.2 and CD3
- Patent number 11,739,145
- Issue date Aug 29, 2023
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized antibody variable regions
- Patent number 11,718,667
- Issue date Aug 8, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 11,673,972
- Issue date Jun 13, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IL-12 heterodimeric Fc-fusion proteins
- Patent number 11,655,277
- Issue date May 23, 2023
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterodimeric proteins
- Patent number 11,634,506
- Issue date Apr 25, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA...
- Patent number 11,618,776
- Issue date Apr 4, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized antibodies that target CD19
- Patent number 11,618,788
- Issue date Apr 4, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralp...
- Patent number 11,584,794
- Issue date Feb 21, 2023
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treating IgE-mediated disorders
- Patent number 11,566,080
- Issue date Jan 31, 2023
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15R...
- Patent number 11,524,991
- Issue date Dec 13, 2022
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
IL-7-FC-fusion proteins
- Patent number 11,512,122
- Issue date Nov 29, 2022
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15...
- Patent number 11,505,595
- Issue date Nov 22, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 11,492,407
- Issue date Nov 8, 2022
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in comb...
- Patent number 11,377,477
- Issue date Jul 5, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IL-12 heterodimeric Fc-fusion proteins
- Patent number 11,358,999
- Issue date Jun 14, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CTLA4-IG immunoadhesins
- Patent number 11,352,412
- Issue date Jun 7, 2022
- Xencor, Inc.
- Gregory A. Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric antibodies that bind CD3 and CD38
- Patent number 11,352,442
- Issue date Jun 7, 2022
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered IL-2 Fc fusion proteins
- Patent number 11,319,355
- Issue date May 3, 2022
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bispecific and monospecific antibodies using novel anti-PD-1 sequences
- Patent number 11,312,770
- Issue date Apr 26, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CTLA4-Ig immunoadhesins
- Patent number 11,254,727
- Issue date Feb 22, 2022
- Xencor, Inc.
- Gregory A. Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific checkpoint inhibitor antibodies
- Patent number 11,236,170
- Issue date Feb 1, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20240132584
- Publication date Apr 25, 2024
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HETERODIMERIC PROTEINS
- Publication number 20240092871
- Publication date Mar 21, 2024
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND GPC3
- Publication number 20240034815
- Publication date Feb 1, 2024
- Xencor, Inc.
- Alex Nisthal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...
- Publication number 20240025968
- Publication date Jan 25, 2024
- Xencor, Inc.
- Matthew J. Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...
- Publication number 20240026002
- Publication date Jan 25, 2024
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3
- Publication number 20240018234
- Publication date Jan 18, 2024
- Astellas Pharma Europe BV
- Matthew BERNETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED ANTIBODY VARIABLE REGIONS
- Publication number 20230399401
- Publication date Dec 14, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
- Publication number 20230365717
- Publication date Nov 16, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED HETERODIMERIC FC FUSION PROTEINS CONTAINING IL-15/IL-15RA...
- Publication number 20230340053
- Publication date Oct 26, 2023
- Xencor, Inc.
- Matthew J. Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED ANTIBODIES THAT TARGET CD19
- Publication number 20230340144
- Publication date Oct 26, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TIM-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...
- Publication number 20230331813
- Publication date Oct 19, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...
- Publication number 20230279071
- Publication date Sep 7, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL HETERODIMERIC PROTEINS
- Publication number 20230279154
- Publication date Sep 7, 2023
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS
- Publication number 20230272114
- Publication date Aug 31, 2023
- Xencor, Inc.
- John R. Desjarlais
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ra...
- Publication number 20230220081
- Publication date Jul 13, 2023
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC ANTIBODIES THAT BIND TO B7H3 AND NKG2D
- Publication number 20230151095
- Publication date May 18, 2023
- Xencor, Inc.
- Katrina Bykova
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3
- Publication number 20230137677
- Publication date May 4, 2023
- Astellas Pharma Europe BV
- Matthew BERNETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS AND USES IN COMB...
- Publication number 20230055445
- Publication date Feb 23, 2023
- Xencor, Inc.
- Matthew Bernett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
- Publication number 20230041377
- Publication date Feb 9, 2023
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-12 HETERODIMERIC FC-FUSION PROTEINS
- Publication number 20230027540
- Publication date Jan 26, 2023
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38
- Publication number 20220403049
- Publication date Dec 22, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-12 HETERODIMERIC FC-FUSION PROTEINS
- Publication number 20220396605
- Publication date Dec 15, 2022
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED ANTIBODY VARIABLE REGIONS
- Publication number 20220380462
- Publication date Dec 1, 2022
- Xencor, Inc.
- Gregory Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL CTLA4-IG IMMUNOADHESINS
- Publication number 20220348634
- Publication date Nov 3, 2022
- Xencor, Inc.
- Gregory A. Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND GPC3
- Publication number 20220306767
- Publication date Sep 29, 2022
- Xencor, Inc.
- Alex Nisthal
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6
- Publication number 20220289839
- Publication date Sep 15, 2022
- Xencor, Inc.
- Matthew S. Faber
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ICOS TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15R...
- Publication number 20220227867
- Publication date Jul 21, 2022
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGINEERED IL-2 Fc FUSION PROTEINS
- Publication number 20220213162
- Publication date Jul 7, 2022
- Xencor, Inc.
- Matthew BERNETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES
- Publication number 20220204624
- Publication date Jun 30, 2022
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS
- Publication number 20220195048
- Publication date Jun 23, 2022
- Xencor, Inc.
- Matthew Bernett
- C07 - ORGANIC CHEMISTRY

Matthew J. Bernett

Person

Patents Grantslast 30 patents

Engineered IL-2 Fc fusion proteins

Heterodimeric antibodies that bind CD3 and tumor antigens

PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved proper...

Heterodimeric antibodies that bind CD3 and GPC3

Heterodimeric antibodies that bind CD3 and tumor antigens

Targeted IL-12 heterodimeric Fc-fusion proteins

Bispecific antibodies that bind to CD38 and CD3

Heterodimeric proteins

Heterodimeric antibodies that bind CD3 and CLDN6

Bispecific binding agents binding to CLDN18.2 and CD3

Optimized antibody variable regions

Heterodimeric antibodies that bind CD3 and tumor antigens

IL-12 heterodimeric Fc-fusion proteins

Heterodimeric proteins

Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA...

Optimized antibodies that target CD19

Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralp...

Compositions and methods for treating IgE-mediated disorders

PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15R...

IL-7-FC-fusion proteins

TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15...

Bispecific checkpoint inhibitor antibodies

PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in comb...

IL-12 heterodimeric Fc-fusion proteins

CTLA4-IG immunoadhesins

Heterodimeric antibodies that bind CD3 and CD38

Engineered IL-2 Fc fusion proteins

Bispecific and monospecific antibodies using novel anti-PD-1 sequences

CTLA4-Ig immunoadhesins

Bispecific checkpoint inhibitor antibodies

Patents Applicationslast 30 patents

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

HETERODIMERIC PROTEINS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND GPC3

LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...

BISPECIFIC IMMUNOMODULATORY ANTIBODIES THAT BIND COSTIMULATORY AND...

BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3

OPTIMIZED ANTIBODY VARIABLE REGIONS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

TARGETED HETERODIMERIC FC FUSION PROTEINS CONTAINING IL-15/IL-15RA...

OPTIMIZED ANTIBODIES THAT TARGET CD19

TIM-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...

LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15...

NOVEL HETERODIMERIC PROTEINS

NOVEL COMPOSITIONS AND METHODS FOR TREATING IgE-MEDIATED DISORDERS

BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ra...

BISPECIFIC ANTIBODIES THAT BIND TO B7H3 AND NKG2D

BISPECIFIC BINDING AGENTS BINDING TO CLDN18.2 AND CD3

PD-1 TARGETED IL-15/IL-15RALPHA FC FUSION PROTEINS AND USES IN COMB...

BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES

IL-12 HETERODIMERIC FC-FUSION PROTEINS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

IL-12 HETERODIMERIC FC-FUSION PROTEINS

OPTIMIZED ANTIBODY VARIABLE REGIONS

NOVEL CTLA4-IG IMMUNOADHESINS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND GPC3

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CLDN6

ICOS TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15R...

ENGINEERED IL-2 Fc FUSION PROTEINS

BISPECIFIC AND MONOSPECIFIC ANTIBODIES USING NOVEL ANTI-PD-1 SEQUENCES

IL15/IL15Ralpha HETERODIMERIC Fc-FUSION PROTEINS